Meet Acumetis at World EPA 2027!
Connect with our GVA team
March 2-3, 2027 | Amsterdam, Netherlands
Acumetis will be attending World EPA Congress 2027 in Amsterdam as a Platinum Sponsor. Our Global Value & Access (GVA) team will be on-site to connect with industry leaders and discuss the evolving challenges of evidence generation, pricing, reimbursement, and access across global markets.
Advancing evidence, pricing, and access strategies
As the evidence, pricing, and access landscape continues to evolve, life sciences organizations are under increasing pressure to demonstrate value clearly and consistently across a wide range of stakeholders.
This is especially true in areas such as rare diseases and other complex therapy areas, where evidence requirements can be challenging and access decisions often require careful alignment across clinical, economic, and payer expectations.
Global Value & Access teams play a critical role in connecting evidence generation, HEOR, value communication, and market access planning to support confident decision-making.
Acumetis helps life sciences organizations develop evidence-led strategies that support successful value demonstration and access outcomes. We work across the product lifecycle to align evidence generation, HTA readiness, pricing strategy, and stakeholder engagement – helping teams build compelling value stories that translate complex evidence into meaningful insights for decision-makers.
We partner with organizations to turn clinical, real-world, and economic evidence into clear, decision-relevant strategies that support reimbursement, access, and long-term value realization.
Key areas of focus
At World EPA Congress 2027, our discussions will center on:
-
- Aligning evidence generation strategies with pricing, reimbursement, and access objectives
- Developing PICO strategies to support HTA and evidence planning
- Leveraging HEOR and real-world evidence to address evidence gaps and strengthen value demonstration
- Navigating rare disease access challenges and complex payer expectations
- Supporting global pricing strategy, including international reference pricing and MFN considerations
- Integrating patient, clinical, and payer perspectives into value communication
- Preparing for HTA and Joint Clinical Assessment (JCA) requirements across markets
- Building cross-functional alignment across GVA, Medical, HEOR, and Commercial teams
Where to Find Us
Acumetis is proud to be a Platinum Sponsor at World EPA Congress 2027.
You’ll find us at Booth #204 throughout the conference – whether you’re looking to recharge, take a break, or have a conversation about your current challenges in evidence, pricing, reimbursement, and access.
We will also be speaking in the Market Access track on Day 2 at 13:00, and chairing a session during the congress, with timing to be confirmed.
About Acumetis
Acumetis partners with life sciences organizations to navigate complex strategic, scientific, and commercial challenges across the product lifecycle.
We bring together medical, access, commercial, insights, and patient strategy into a coordinated path forward, building the knowledge and clarity that strengthen decision-making.
Our work spans Medical Affairs, Market Access, and Commercial Strategy, supporting teams in connecting evidence, engagement, and execution to drive meaningful outcomes.
At the core of our approach is a focus on reframing challenges, bringing strategic clarity, and creating critical connections that enable progress in practice.
Who You’ll Meet
Members of our Global Value & Access team will be attending World EPA Congress 2027.
Attendee details will be confirmed closer to the event.
Schedule a meeting with the Acumetis team to discuss your priorities and explore how we can support your evidence, value, pricing, and access strategy.